Josh EnomotoInvestorPlace Contributor
About Josh Enomoto
As a financial analyst who has engaged in multimillion dollar projects with Global 500 companies, Joshua Enomoto provides an acute perspective of the investment markets.
A graduate of the University of California, San Diego, his professional experience covers multiple industries, including healthcare, civil engineering, and consumer electronics. Past contributions include leading the resolution of a critical liabilities dispute between two major electronics companies, and being awarded a speaking engagement in Tokyo, Japan, regarding supply chain efficiency protocols.
Currently based in San Diego, Josh is also an avid music composer and audio engineer, and spends his free time with multimedia pursuits.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus advice on the best stocks to buy & sell now.
Here are seven stocks to buy if you're optimistic about the potential for alternative therapies to become mainstream treatments.
Although the weakening of pandemic-related catalysts could slow e-commerce growth, AMZN stock is still worth believing in.
Although the market is firing on all cylinders again, it’s time to consider trimming risk exposure in these stocks to sell.
Prospective buyers should really perform their ‘DD’ before deciding if they want to buy MMAT stock. It's more than a meme but needs time.
With rising market valuations making many investors fearful of holding the bag, these best ETFs to buy now can help mitigate risk.